Cargando…

Low-Carbohydrate Diet for the Treatment of Gestational Diabetes Mellitus: A randomized controlled trial

OBJECTIVE: Medical nutrition therapy based on the control of the amount and distribution of carbohydrates (CHO) is the initial treatment for gestational diabetes mellitus (GDM), but there is a need for randomized controlled trials comparing different dietary strategies. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Castilla, Cristina, Hernandez, Marta, Bergua, Merce, Alvarez, Maria C., Arce, Maria A., Rodriguez, Karen, Martinez-Alonso, Montserrat, Iglesias, Montserrat, Mateu, Magdalena, Santos, Maria D., Pacheco, Linda R., Blasco, Yolanda, Martin, Eva, Balsells, Nuria, Aranda, Nuria, Mauricio, Didac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714525/
https://www.ncbi.nlm.nih.gov/pubmed/23564917
http://dx.doi.org/10.2337/dc12-2714
Descripción
Sumario:OBJECTIVE: Medical nutrition therapy based on the control of the amount and distribution of carbohydrates (CHO) is the initial treatment for gestational diabetes mellitus (GDM), but there is a need for randomized controlled trials comparing different dietary strategies. The purpose of this study was to test the hypothesis that a low-CHO diet for the treatment of GDM would lead to a lower rate of insulin treatment with similar pregnancy outcomes compared with a control diet. RESEARCH DESIGN AND METHODS: A total of 152 women with GDM were included in this open, randomized controlled trial and assigned to follow either a diet with low-CHO content (40% of the total diet energy content as CHO) or a control diet (55% of the total diet energy content as CHO). CHO intake was assessed by 3-day food records. The main pregnancy outcomes were also assessed. RESULTS: The rate of women requiring insulin was not significantly different between the treatment groups (low CHO 54.7% vs. control 54.7%; P = 1). Daily food records confirmed a difference in the amount of CHO consumed between the groups (P = 0.0001). No differences were found in the obstetric and perinatal outcomes between the treatment groups. CONCLUSIONS: Treatment of women with GDM using a low-CHO diet did not reduce the number of women needing insulin and produced similar pregnancy outcomes. In GDM, CHO amount (40 vs. 55% of calories) did not influence insulin need or pregnancy outcomes.